Risk factor
Very high price volatility
Profitability factor
Very strong margins and returns
About
Supriya Lifescience Ltd. is an Indian pharmaceutical enterprise, established in 1987 and headquartered in Mumbai. The company's primary business involves the global research, development, manufacturing, and commercialization of Active Pharmaceutical Ingredients (APIs), positioning it as a significant producer of bulk drug components. Its extensive range of APIs caters to diverse therapeutic areas, including anti-histamines, anti-allergics, anti-asthmatics, decongestants, analgesics, antipyretics, anesthetics, smoking cessation aids, anti-hypertensives, and anti-malarials. Additionally, Supriya Lifescience also supplies various other products, such as vitamins, animal feed additives, xanthine derivatives (some of which are used in beverages), and phytochemicals.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV
Target Price
The average target price of SUPRIYA.NS is 987 and suggests 4% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendat